Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis

Por Tiano, Joseph P., Tate, Chandra R., Yang, Bin S., DiMarchi, Richard, Mauvais-Jarvis, Franck
Publicado no Sci Rep (2015)

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

Por Tate, Chandra R, Rhodes, Lyndsay V, Segar, H Chris, Driver, Jennifer L, Pounder, F Nell, Burow, Matthew E, Collins-Burow, Bridgette M
Publicado em 2012

Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice()

Por Kim, Jun Ho, Meyers, Matthew S., Khuder, Saja S., Abdallah, Simon L., Muturi, Harrison T., Russo, Lucia, Tate, Chandra R., Hevener, Andrea L., Najjar, Sonia M., Leloup, Corinne, Mauvais-Jarvis, Franck
Publicado em 2014

Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells

Por Rhodes, Lyndsay V., Bratton, Melyssa R., Zhu, Yun, Tilghman, Syreeta L., Muir, Shannon E., Salvo, Virgilio A., Tate, Chandra R., Elliott, Steven, Nephew, Kenneth P., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado em 2011

Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators

Por Rhodes, Lyndsay V., Tate, Chandra R., Segar, H. Chris, Burks, Hope E., Phamduy, Theresa B., Hoang, Van, Elliott, Steven, Gilliam, Diari, Pounder, F. Nell, Anbalagan, Muralidharan, Chrisey, Douglas B., Rowan, Brian G., Burow, Matthew E., Collins-Burow, Bridgette M.
Publicado em 2014